CEBINA is the Central European Biotech Incubator and Accelerator, an Austrian-based biotech company bringing together its in-house research, development, financing, and management capabilities to support early and medium stage biotech companies, and to develop a pipeline of innovative projects and spin-out companies.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 3,700 employees provide the highest quality stand-alone and integrated drug discovery and development solutions from target to clinic.
CEBINA Bridge Capital is a regulated AIFMD fund registered in Gibraltar. The AIFMD structure allows for superior transparency and accounts for improved reporting standards all leading to greater investor protection.
The fund is focused on financing seed capital into biotechnology opportunities sourced by CEBINA GmbH and Evotec SE from institutions within Austria and Central and Eastern Europe.